Skip to content
Search

Latest Stories

Lloyds Pharmacy’s decision to close all Sainsbury’s branches worries pharmacy bodies

The pharmacy bodies have expressed a deep concern over Lloyds Pharmacy ’s announcement on plans to close all pharmacy branches located in Sainsbury’s before the end of 2023.

Pharmaceutical Services Negotiating Committee (PSNC) Chief Executive Janet Morrison said: “This significant shrinkage by the second largest pharmacy chain is an extremely worrying development and one of the clearest signals yet of just how much all community pharmacies are struggling to make ends meet. We know that many are at breaking point.”


She added: “We understand that LloydsPharmacy will be in touch directly with affected staff and patients at this difficult time. As these pharmacies close, other pharmacies locally will be braced for even more pressures as they try to cope with increased demand.”

“The announcement by LloydsPharmacy will be of concern to staff, patients, the public and the community pharmacy sector alike,” Malcolm Harrison, Chief Executive of the Company Chemists’ Association (CCA).

Pharmacists, and other employees, working at pharmacies owned and operated by LloydsPharmacy in Sainsbury’s have been told that the group of more than 200 pharmacies will be closed this year as LloydsPharmacy will be ending their relationship with the supermarket chain.

The Pharmacist Defence Association (PDA) Union will provide PDA members with information, support and representation in order that they are aware of and can exercise their rights at work in relation to this situation.

As the recognised trade union at LloydsPharmacy, PDA officials were given confidential notice before the announcement and are able to continue to represent the interests of pharmacists in discussions with the company.

Mark Pitt, Assistant General Secretary of the PDA Union said, “We have seen many disposals of Lloyds Pharmacy branches over recent months and we know more may occur, however for every disposal there has been a buyer, therefore patients and communities have seen no reduction in availability, the pharmacy network has not lost capacity and there were no job losses.

This situation is different and means significant reductions in access to a pharmacy for patients and we expect those who represent communities to be concerned about the loss of a key part of their local NHS service.

Forward-thinking governments around the UK are seeking to make greater use of pharmacies as the most accessible contact point in the NHS, to reduce pressure on other parts of the healthcare system, so there should be greater community pharmacy capacity, not less.”

According to PSNC, the sharp decline in community pharmacy funding combined with workforce and other pressures is making it ‘increasingly difficult to sustain services and impossible to do more’.

The committee stressed that pharmacies urgently need investment from Government to ensure they can continue to offer the services that so many patients rely on and this is why the sector has this week announced its #saveourpharmacies campaign.

Morrison said: “Without further investment, we believe more permanent closures are likely and this will only increase the risk of serious difficulty for patients’ in accessing services and medicines: Government must not allow this to happen. I am calling on Ministers to meet me for meaningful talks to avoid such a catastrophe.”

“Policymakers cannot escape the fact that the funding model for community pharmacy is broken,” said Harrison.

“As we and other pharmacy bodies have warned recently, we are at an indisputable fork in the road for the NHS. At a time when General Practice and the NHS is struggling with ever-increasing demand, allowing the community pharmacy network to wither and decline will make no sense to patients and the public. Again, we call on the Government to act.

If new and recurrent funding is not forthcoming, it is very likely that the rate of permanent closures will increase with far-reaching impacts on the capacity and resilience of the pharmacy network.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less